Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS)
Phuong Tram Nguyen(University of Tasmania), Bruce Taylor(University of London), Kaylene M. Young(University of Saskatchewan), Chigozie Ezegbe(University of Tasmania), Natasha Stevens(University of Tasmania), Kalina Makowiecki(Center for Neuroscience and Regenerative Medicine), Samantha Cooper(University of Wisconsin–Milwaukee), Amin Zarghami(University of Tasmania), Jennifer Rodger(The University of Western Australia), Mark R. Hinder(University of Tasmania), Michael Barnett(The University of Sydney), Lewis Johnson(University of Tasmania), Kain Kyle(Cooperative Trials Group for Neuro-Oncology), Chenyu Wang(Wuhan University), Carlie L. Cullen(University of Tasmania), Linda Ly(Cooperative Trials Group for Neuro-Oncology), Katie De La Rue(University of Tasmania)
Cited by 3
Related Papers
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
|Neurology|2014|1.3k
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
|Annals of Neurology|2010|453
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
|Journal of Neurology|2007|322